Literature DB >> 9501810

Role of ultrasonographically guided fine-needle aspiration cytology in the diagnosis of infected pancreatic necrosis.

B Rau1, U Pralle, J M Mayer, H G Beger.   

Abstract

BACKGROUND: Early detection of infected pancreatic necrosis has a major impact on further management and outcome in acute pancreatitis. The aim of this study was to evaluate the clinical value of ultrasonographically guided fine-needle aspiration cytology (FNAC) in patients with necrotizing pancreatitis over an 8-year period.
METHODS: From January 1988 to September 1996 193 (mean 2.0 (range 1-9) aspirations per patient) prospectively assessed FNACs guided ultrasonographically were performed in 98 patients with necrotizing pancreatitis proven by contrast-enhanced computed tomography. Aspirates were considered infected if either Gram stain and/or culture revealed micro-organisms.
RESULTS: Ultrasonographically guided FNAC correctly diagnosed infection in 29 of 33 patients with infected necrosis a median of 13 days after onset of symptoms. Of 61 patients with sterile necrosis 55 were identified correctly as sterile by FNAC. There were six false-positive and four false-negative aspirates of which nine occurred during the first week of the disease. In four patients who did not undergo operation FNAC revealed Gram-negative organisms; however, in the absence of repeated aspirations, the positive results remained unconfirmed. An overall sensitivity of 88 per cent and a specificity of 90 per cent was obtained. No difference was found in biochemical and clinical parameters indicating systemic inflammatory response syndrome before each FNAC between patients with proven sterile or infected necrosis. All patients tolerated the procedure well and no major complications were observed.
CONCLUSION: Ultrasonographically guided FNAC is a fast and reliable technique for the diagnosis of infected necrosis. As complication rates are very low, the procedure can be repeated at short intervals to improve the diagnostic accuracy. Ultrasonographically guided FNAC is recommended for all patients with necrotizing pancreatitis in whom systemic inflammatory response syndrome persists beyond the first week after onset of symptoms.

Entities:  

Mesh:

Year:  1998        PMID: 9501810     DOI: 10.1046/j.1365-2168.1998.00707.x

Source DB:  PubMed          Journal:  Br J Surg        ISSN: 0007-1323            Impact factor:   6.939


  33 in total

Review 1.  Management of acute pancreatitis: from surgery to interventional intensive care.

Authors:  J Werner; S Feuerbach; W Uhl; M W Büchler
Journal:  Gut       Date:  2005-03       Impact factor: 23.059

2.  UK guidelines for the management of acute pancreatitis.

Authors: 
Journal:  Gut       Date:  2005-05       Impact factor: 23.059

3.  Percutaneous management of necrotizing pancreatitis.

Authors:  Ross Carter
Journal:  HPB (Oxford)       Date:  2007       Impact factor: 3.647

Review 4.  Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini consensus conference.

Authors:  C Dervenis; C D Johnson; C Bassi; E Bradley; C W Imrie; M J McMahon; I Modlin
Journal:  Int J Pancreatol       Date:  1999-06

5.  Case-matched comparison of the retroperitoneal approach with laparotomy for necrotizing pancreatitis.

Authors:  Hjalmar C van Santvoort; Marc G Besselink; Thomas L Bollen; Erik Buskens; Bert van Ramshorst; Hein G Gooszen
Journal:  World J Surg       Date:  2007-06-16       Impact factor: 3.352

Review 6.  [Therapy of chronic pancreatitis].

Authors:  J Mössner; V Keim
Journal:  Internist (Berl)       Date:  2003-12       Impact factor: 0.743

Review 7.  Severe acute pancreatitis: Clinical course and management.

Authors:  Hans G Beger; Bettina M Rau
Journal:  World J Gastroenterol       Date:  2007-10-14       Impact factor: 5.742

8.  Successful outcome with conservative management of emphysematous pancreatitis.

Authors:  Nikhil Nadkarni; Sanjay D'Cruz; Ravinder Kaur; Atul Sachdev
Journal:  Indian J Gastroenterol       Date:  2013-04-12

9.  Impact of alanyl-glutamine dipeptide on severe acute pancreatitis in early stage.

Authors:  Ping Xue; Li-Hui Deng; Qing Xia; Zhao-Da Zhang; Wei-Ming Hu; Xiao-Nan Yang; Bing Song; Zong-Wen Huang
Journal:  World J Gastroenterol       Date:  2008-01-21       Impact factor: 5.742

Review 10.  Severe acute pancreatitis: pathogenetic aspects and prognostic factors.

Authors:  Ibrahim-A Al Mofleh
Journal:  World J Gastroenterol       Date:  2008-02-07       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.